Since its start in 1984 The Kay Kendall Leukaemia Fund has awarded grants for research on aspects of leukaemia and for relevant studies on related haematological malignancies. Awards have been made for fellowships, project grants, and capital builds and have contributed significantly to the progress and body of research in this area.
In 2008 Trustees instigated a new programme of patient care and patient centred projects associated with leukaemia and haematological diseases making awards towards significant appeals, capital builds, or other initiatives with a strong patient-care focus for leukaemia patients, their families, and carers.
The Kay Kendall Leukaemia Fund has now completed its active grant-making and will no longer accept applications for either the research or the patient care funding programmes. It will continue to manage current grants and information for current grant holders is at ‘Current Grant Holders’.
The Kay Kendall Leukaemia Fund is one of 17 different independent grant-making trusts established by members of three generations of the Sainsbury family. Each trust is an independent legal entity with its own separate and autonomous board of trustees.
The Kay Kendall Leukaemia Fund is registered as a data controller with the UK Information Commissioner’s Office